Serina Therapeutics, Inc. Increase (Decrease) in Other Current Liabilities
Serina Therapeutics, Inc. (SER) reported Increase (Decrease) in Other Current Liabilities of -$17.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentLiabilities · last filed 2026-08-13
- Serina Therapeutics, Inc. increase (decrease) in other current liabilities for the quarter ending 2026-06-30 was -$23.00K, a 106.25% decline year-over-year.
- Serina Therapeutics, Inc. increase (decrease) in other current liabilities for the quarter ending 2026-03-31 was $6.00K.
- Serina Therapeutics, Inc. increase (decrease) in other current liabilities for the quarter ending 2025-12-31 was -$168.00K.
- Serina Therapeutics, Inc. increase (decrease) in other current liabilities for the quarter ending 2025-09-30 was -$182.00K, a 398.36% decline year-over-year.
- Serina Therapeutics, Inc. increase (decrease) in other current liabilities for fiscal 2025 was $18.00K.
- Serina Therapeutics, Inc. increase (decrease) in other current liabilities for fiscal 2024 was $0.00.
- Serina Therapeutics, Inc. increase (decrease) in other current liabilities for fiscal 2023 was -$4.00K.
- Serina Therapeutics, Inc. increase (decrease) in other current liabilities for fiscal 2022 was -$4.00K.
| Period end | Increase (Decrease) in Other Current Liabilities 3 month | Increase (Decrease) in Other Current Liabilities 6 month | Increase (Decrease) in Other Current Liabilities 6 month as first filed | Increase (Decrease) in Other Current Liabilities 9 month | Increase (Decrease) in Other Current Liabilities 12 month | Increase (Decrease) in Other Current Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$17.00K 10-Q · filed 2026-08-13 | -$185.00K derived: sum of 3 quarters · filed 2026-08-13 | -$367.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2026-03-31 | $6.00K 10-Q · filed 2026-05-14 | -$162.00K derived: sum of 2 quarters · filed 2026-05-14 | -$344.00K derived: sum of 3 quarters · filed 2026-05-14 | $24.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-12-31 | -$168.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$350.00K derived: sum of 2 quarters · filed 2026-03-25 | $18.00K derived: sum of 3 quarters · filed 2026-08-13 | $18.00K 10-K · filed 2026-03-25 | ||
| 2025-09-30 | -$182.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $186.00K derived: sum of 2 quarters · filed 2026-08-13 | $186.00K 10-Q · filed 2025-11-13 | $186.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-06-30 | $368.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $368.00K 10-Q · filed 2026-08-13 | $368.00K derived: sum of 3 quarters · filed 2026-08-13 | $429.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 | $0.00 derived: sum of 2 quarters · filed 2026-05-14 | $61.00K derived: sum of 3 quarters · filed 2026-05-14 | -$3.00K derived: sum of 4 quarters · filed 2026-05-14 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $61.00K derived: sum of 2 quarters · filed 2026-03-25 | -$3.00K derived: sum of 3 quarters · filed 2026-03-25 | $0.00 10-K · filed 2026-03-25 | ||
| 2024-09-30 | $61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$3.00K derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | -$9.00K derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | -$64.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$61.00K 10-Q · filed 2025-08-11 | $5.00K 10-Q · filed 2024-08-09 | -$70.00K derived: sum of 3 quarters · filed 2025-08-11 | -$70.00K derived: sum of 4 quarters · filed 2025-08-11 | |
| 2024-03-31 | $3.00K 10-Q · filed 2024-05-14 | -$6.00K derived: sum of 2 quarters · filed 2024-05-14 | -$6.00K derived: sum of 3 quarters · filed 2024-05-14 | -$7.00K derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2023-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$9.00K derived: sum of 2 quarters · filed 2024-03-22 | -$10.00K derived: sum of 3 quarters · filed 2024-03-22 | -$4.00K 10-K · filed 2024-03-22 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$1.00K derived: sum of 2 quarters · filed 2023-11-14 | $5.00K 10-Q · filed 2023-11-14 | $3.00K derived: sum of 4 quarters · filed 2024-03-22 | ||
| 2023-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $5.00K 10-Q · filed 2023-08-14 | $3.00K derived: sum of 3 quarters · filed 2024-03-22 | $3.00K derived: sum of 4 quarters · filed 2024-03-22 | ||
| 2023-03-31 | $6.00K 10-Q · filed 2023-05-12 | $4.00K derived: sum of 2 quarters · filed 2024-03-22 | $4.00K derived: sum of 3 quarters · filed 2024-03-22 | $3.00K derived: sum of 4 quarters · filed 2024-03-22 | ||
| 2022-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$2.00K derived: sum of 2 quarters · filed 2024-03-22 | -$3.00K derived: sum of 3 quarters · filed 2024-03-22 | -$4.00K 10-K · filed 2024-03-22 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$1.00K derived: sum of 2 quarters · filed 2023-11-14 | -$2.00K 10-Q · filed 2023-11-14 | -$4.00K derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$2.00K 10-Q · filed 2023-08-14 | -$4.00K derived: sum of 3 quarters · filed 2023-08-14 | -$5.00K derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | -$1.00K 10-Q · filed 2023-05-12 | -$3.00K derived: sum of 2 quarters · filed 2023-05-12 | -$4.00K derived: sum of 3 quarters · filed 2023-05-12 | -$26.00K derived: sum of 4 quarters · filed 2023-05-12 | ||
| 2021-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$3.00K derived: sum of 2 quarters · filed 2023-03-31 | -$25.00K derived: sum of 3 quarters · filed 2023-03-31 | -$79.00K 10-K · filed 2023-03-31 | ||
| 2021-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$23.00K derived: sum of 2 quarters · filed 2022-11-10 | -$77.00K 10-Q · filed 2022-11-10 | -$225.00K derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | -$22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$76.00K 10-Q · filed 2022-08-12 | -$224.00K derived: sum of 3 quarters · filed 2022-08-12 | -$368.00K derived: sum of 4 quarters · filed 2022-08-12 | ||
| 2021-03-31 | -$54.00K 10-Q · filed 2022-05-13 | -$202.00K derived: sum of 2 quarters · filed 2022-05-13 | -$346.00K derived: sum of 3 quarters · filed 2022-05-13 | -$503.00K derived: sum of 4 quarters · filed 2022-05-13 | ||
| 2020-12-31 | -$148.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$292.00K derived: sum of 2 quarters · filed 2022-03-29 | -$449.00K derived: sum of 3 quarters · filed 2022-03-29 | -$577.00K 10-K · filed 2022-03-29 | -$610.00K 10-K · filed 2021-03-31 | |
| 2020-09-30 | -$144.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$301.00K derived: sum of 2 quarters · filed 2021-11-12 | -$429.00K 10-Q · filed 2021-11-12 | |||
| 2020-06-30 | -$157.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$285.00K 10-Q · filed 2021-08-13 | ||||
| 2020-03-31 | -$128.00K 10-Q · filed 2021-05-17 | |||||
| 2019-12-31 | -$119.00K 10-K · filed 2021-03-31 | |||||
| 2018-12-31 | -$129.00K 10-K/A · filed 2020-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |